| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
Departments of Pathology [A. G., O. W. R., M. B. C.] and Urology [M. B. C.], University of Iowa, Iowa City, Iowa 52242, and Veterans Affairs Medical Center, Iowa City, Iowa 52240 [M. B. C.]
We have shown previously that the pathways leading to Fas-mediated apoptosis in prostatic carcinoma cell lines are intact, because apoptosis can be triggered either by Fas ligation alone in the Fas-sensitive cell lines PC3 and ALVA31 or by rendering the Fas-resistant cell lines DU145 and JCA1 Fas-sensitive by combined treatment with anti-Fas monoclonal antibody and cycloheximide (O. W. Rokhlin et al., Cancer Res., 57: 17581768, 1997). In this study, we demonstrate that two of the early events after Fas ligation are the release of cytochrome c from the mitochondria and activation of caspase-9. We also found that Bid is processed after Fas ligation and thus might activate the mitochondria-dependent apoptotic cascade. In a cell-free system, cytochrome c induced caspase-3-like activity in cytoplasmic extracts from all four cell lines studied, although differences in the level of enzymatic activity were observed. Western blot analysis revealed that caspase-7 is activated by cytochrome c at the same level in all extracts, whereas expression and activation of caspase-3 varied considerably. Cytochrome c-activated extracts displayed different abilities in the induction of apoptotic features in isolated nuclei such as morphological changes and DNA fragmentation. However, differences in nuclear apoptotic activity induced by cytochrome c did not correlate with the level of caspase-3 like activity in the different extracts. These results suggest that the mitochondrial pathway is involved in Fas-mediated apoptosis in prostatic carcinoma cell lines and that, in addition to caspase-7 and caspase-3, there are other factors that confer nuclear apoptotic activity.
This article has been cited by other articles:
![]() |
M. Wu, Y. Chen, K. Wilson, A. Chirindel, M. A. Ihnat, Y. Yu, M. E. Boulton, L. I. Szweda, J.-X. Ma, and T. J. Lyons Intraretinal Leakage and Oxidation of LDL in Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2679 - 2685. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nomura-Takigawa, M. Nagano-Fujii, L. Deng, S. Kitazawa, S. Ishido, K. Sada, and H. Hotta Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis J. Gen. Virol., July 1, 2006; 87(7): 1935 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Qanungo, M. Das, S. Haldar, and A. Basu Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells Carcinogenesis, May 1, 2005; 26(5): 958 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gopalan, A. Litvak, S. Sharma, A. M. Mhashilkar, S. Chada, and R. Ramesh Activation of the Fas-FasL Signaling Pathway by MDA-7/IL-24 Kills Human Ovarian Cancer Cells Cancer Res., April 15, 2005; 65(8): 3017 - 3024. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Kawakami, S Urayama, S Yamasaki, A Hida, T Miyashita, M Kamachi, K Nakashima, F Tanaka, H Ida, Y Kawabe, et al. Anti-apoptogenic function of TGF{beta}1 for human synovial cells: TGF{beta}1 protects cultured synovial cells from mitochondrial perturbation induced by several apoptogenic stimuli Ann Rheum Dis, January 1, 2004; 63(1): 95 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fornaro, J. Plescia, S. Chheang, G. Tallini, Y.-M. Zhu, M. King, D. C. Altieri, and L. R. Languino Fibronectin Protects Prostate Cancer Cells from Tumor Necrosis Factor-{alpha}-induced Apoptosis via the AKT/Survivin Pathway J. Biol. Chem., December 12, 2003; 278(50): 50402 - 50411. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Agarwal, R. P. Singh, and R. Agarwal Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release Carcinogenesis, November 1, 2002; 23(11): 1869 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. W. Rokhlin, R. A. Glover, A. F. Taghiyev, N. V. Guseva, R. E. B. Seftor, I. Shyshynova, A. V. Gudkov, and M. B. Cohen Bisindolylmaleimide IX Facilitates Tumor Necrosis Factor Receptor Family-mediated Cell Death and Acts as an Inhibitor of Transcription J. Biol. Chem., August 30, 2002; 277(36): 33213 - 33219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chakraborty, S. G. Qiu, K. M. Vasudevan, and V. M. Rangnekar Par-4 Drives Trafficking and Activation of Fas and FasL to Induce Prostate Cancer Cell Apoptosis and Tumor Regression Cancer Res., October 1, 2001; 61(19): 7255 - 7263. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Y. Wong, W. P. Wang, C. H. Cho, X. M. Fan, M. C. M. Lin, H. F. Kung, and S. K. Lam 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells Carcinogenesis, September 1, 2001; 22(9): 1349 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huang, Q. He, M. J. Hillman, R. Rong, and M. S. Sheikh Sulindac Sulfide-induced Apoptosis Involves Death Receptor 5 and the Caspase 8-dependent Pathway in Human Colon and Prostate Cancer Cells Cancer Res., September 1, 2001; 61(18): 6918 - 6924. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-C. Yu, Y. Chen, J. Dilley, Y. Li, M. Embry, H. Zhang, N. Nguyen, P. Amin, J. Oh, and D. R. Henderson Antitumor Synergy of CV787, a Prostate Cancer-specific Adenovirus, and Paclitaxel and Docetaxel Cancer Res., January 1, 2001; 61(2): 517 - 525. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |